Paragraph 15 Continuing validity of nominations
The amendments made by paragraph 66(1) and (2) of Schedule 2 do not affect the continuation of any person's nomination as a legal representative for the purposes of Schedule 1 to the Medicines for Human Use (Clinical Trials) Regulations 2004 M1 if that person was nominated by a Primary Care Trust or Strategic Health Authority.
Annotations
Marginal citations
- M1
S.I. 2004/1031, to which there are amendments not relevant to this Order.